Acute Lymphoblastic Leukemia
A Phase I Study of Induction Therapy with Cytarabine, High-Dose Mitoxantrone, and Dasatinib for Patients with Philadelphia-Chromosome Positive Acute Lymphoblastic Leukemia
Weiss, Mark, MD
[Protocol 09-046]
A Phase II Multicenter Trial of Myeloablative Double Unit Umbilical Cord Blood Transplantation in Adults with Hematological Cancers
Barker, Juliet, MBBS
[Protocol 07-072]
A Reduced Intensity Conditioning Regimen and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with Acute Leukemia or Myelodysplasia
Barker, Juliet, MBBS
[Protocol 08-087]
Classification of Acute Lymphoblastic Leukemia
Shukla, Neerav, MD
[Protocol 06-023]
Chronic Lymphocytic Leukemia
A Non-Myeloablative Conditioning Regimen with Peri-Transplant Rituximab and the Transplantation of Unrelated Donor Umbilical Cord Blood in Patients with B cell Lymphoid Malignancies
Barker, Juliet, MBBS
[Protocol 06-066]
A Phase I Study of Genetically Modified T Cells to Treat Recurrent or Refractory Chronic Lymphocytic Leukemia
Brentjens, Renier, MD, PhD
[Protocol 06-138]
A Phase I-II Study of Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Previously Treated Patients with Chronic Lymphocytic Leukemia and Other Low Grade B-Cell Cancers
Lamanna, Nicole, MD
[Protocol 05-077]
A Phase I/II Study of Bortezomib with Rituximab, Cyclophosphamide, and Prednisone in Patients with Relapsed/Refractory Indolent B-cell Lymphoproliferative Disorders and Mantle Cell Lymphoma (MCL)
Gerecitano, John, MD, PhD
[Protocol 05-103]
A Phase II Study of Pentostatin with Cyclophosphamide and Rituximab for Previously Untreated Patients with Chronic Lymphocytic Leukemia
Weiss, Mark, MD
[Protocol 05-051]
Chronic Myelocytic Leukemia 
